Page last updated: 2024-08-26

phorbolol myristate acetate and Cancer of Liver

phorbolol myristate acetate has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Jin, X; Li, H; Mao, J; Wang, L; Xu, B; Yuan, J; Zhang, H; Zhu, J	1

Other Studies

1 other study(ies) available for phorbolol myristate acetate and Cancer of Liver

Article	Year
Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blocking the swelling-activated chloride current. Journal of cellular physiology, 2013, Volume: 228, Issue:5 Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Size; Chloride Channels; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Metastasis; Receptors, Estrogen; RNA, Small Interfering; Tamoxifen; Tetradecanoylphorbol Acetate	2013

Article

Year

Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blocking the swelling-activated chloride current.

Journal of cellular physiology, 2013, Volume: 228, Issue:5

Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Size; Chloride Channels; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Metastasis; Receptors, Estrogen; RNA, Small Interfering; Tamoxifen; Tetradecanoylphorbol Acetate

2013